Published in Pharma Investments, Ventures and Law Weekly, January 13th, 2008
"The objective of this work was to evaluate the novel chelating agent SarAr...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.